Exhibit 2.1
STOCK PURCHASE AGREEMENT
This Stock Purchase Agreement (this “Agreement”) is made and entered into as of November 18, 2026 (the “Execution Date”), by and among:
All In FutureTech Alliance Inc., a corporation duly incorporated and validly existing under the laws of the State of Delaware (“Buyer” or “AIFA”),
Li Shanglong, an individual who, as of the Execution Date, serves as a director and the chairman of the board of directors of Buyer (“Seller”), and
Little Vault Inc., a corporation duly incorporated and validly existing under the laws of the State of California (the “Company”).
Buyer, Seller and the Company are each referred to as a “Party” and collectively as the “Parties.”
Recitals
A. Seller is the record and beneficial owner of all of the issued and outstanding shares of capital stock of the Company (the “Purchased Shares”).
B. The Company operates a multi-channel network and personal intellectual property commercialization platform focused on key opinion leaders, celebrities, professionals, experts and other content creators, including content planning, production, account operation, audience growth, courses and training, advertising, brand cooperation, livestreaming, e-commerce, paid content and platform revenue sharing (the “Business”).
C. Before Closing, Seller and the Company shall complete the Pre-Closing Restructuring in accordance with all applicable Laws and to Buyer’s satisfaction, so that, as of Closing, the rights and economic interests comprised in the Pre-Closing Restructuring are validly vested in the Company through direct transfers or lawful indirect arrangements approved by Buyer in writing, with effective control of commercialization, revenue collection and enforcement.
D. Buyer desires to purchase from Seller, and Seller desires to sell to Buyer, all of the Purchased Shares, so that the Company will become a direct or indirect wholly owned subsidiary of Buyer, on the terms and subject to the conditions set forth herein.
E. Seller acknowledges that he has a material personal and financial interest in the transactions because he owns the Purchased Shares and will receive the Consideration Shares while serving as a director and chairman of Buyer. Buyer shall act through an independent and disinterested special committee of its board (the “Special Committee”) in evaluating, negotiating and overseeing this Related Party Transaction. Seller shall disclose his interests and recuse himself as provided herein.
1
Now, therefore, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the Parties agree as follows:
ARTICLE I
Definitions and Interpretation
Section 1.01 Definitions.
“AIFA Common Stock” means the common stock, par value US$0.0001 per share, of Buyer.
“Affiliate” means with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with that Person; “control” means the power to direct management or policies through ownership, contract or otherwise.
“Ancillary Documents” means the IP Cooperation Agreement covering all Seller Personal IP, the other Key Personal IP Partner undertakings, transfer, surrender and retransfer instruments and undertakings executed and delivered pursuant to this Agreement. A document predating this Agreement is not preserved as an Ancillary Document unless it is expressly re-executed or expressly incorporated by a writing signed by all Parties in accordance with Section 11.06.
“Business Day” means a day other than Saturday, Sunday or a day on which commercial banks in New York City or Hong Kong are authorized or required by Law to close.
“Closing” means the consummation of the sale and purchase of the Purchased Shares under Article IV.
“Closing Date” means the date on which the Closing occurs.
“Company Intellectual Property” means all Intellectual Property owned or purported to be owned by the Company or used in the Business, including content, course materials, copyrights, trademarks, domain names, social-media handles, platform accounts, databases, software, analytics, audience data and rights licensed from Personal IP Partners, including rights in Seller Personal IP under the IP Cooperation Agreement.
“Seller Personal IP” means all worldwide intellectual property, publicity, personality and commercial rights owned, controlled or licensable by Seller that relate to Seller’s identity, reputation, activities or content, including Seller’s name, image, likeness, voice, signature, persona, biography, trademarks, copyrights, content, recordings, photographs, videos, courses, curricula, social-media accounts and handles, platform accounts, audience data, goodwill and all adaptations and derivative works of the foregoing.
“Consideration Shares” means the newly issued shares of AIFA Common Stock issuable to Seller under Article III, as adjusted under this Agreement.
“Disinterested Director” means a member of Buyer’s board of directors who is not a party to the transactions contemplated by this Agreement and does not have a material interest in, or a material relationship with a Person having a material interest in, those transactions, in each case as determined under applicable Delaware Law and the Nasdaq Rules.
2
“Related Party Transaction” means the transactions contemplated by this Agreement and any related transaction required to be reviewed or disclosed as a transaction with a related person under Item 404 of Regulation S-K or the Nasdaq Rules.
“Special Committee” means a committee of at least two independent and Disinterested Directors established by Buyer’s board, with authority to retain independent advisers, obtain information, negotiate or oversee negotiations, reject the transactions and oversee performance and enforcement without direction from Seller.
“Contract” means any written or oral agreement, lease, license, commitment or other legally binding arrangement.
“Encumbrance” means any lien, pledge, security interest, option, charge, mortgage, adverse claim, voting restriction, right of first refusal or other encumbrance, other than restrictions arising under applicable securities Laws.
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
“Fiscal Year” means each calendar year ending December 31.
“Fraud” means, with respect to any Person, an intentional misrepresentation or omission of a material fact, or reckless indifference to its truth, in the making of any representation or warranty in this Agreement, any Transaction Document or any certificate delivered under them, or in any information furnished under Section 8.04 or 8.05, made with the intent of inducing another Party to rely on it, and on which that Party relied.
“Governmental Authority” means any domestic or foreign governmental, regulatory, judicial or administrative authority, including the SEC and Nasdaq.
“IP Cooperation Agreement” means the exclusive intellectual property license, commercialization and revenue-assignment agreement to be executed before Closing by Seller in his personal capacity and the Company, implementing Sections 6.20, 8.03 and 8.08 for all Seller Personal IP. It shall confer on the Company the exclusive worldwide commercialization and full revenue rights required by those Sections, provide for lawful post-Closing transfers within Buyer and its Wholly Owned Subsidiaries under Section 8.08(b), and shall not narrow the continuing obligations in this Agreement.
“Key Personal IP Partners” means Seller and each Personal IP Partner identified on Schedule A. Seller and all Seller Personal IP are covered by this Agreement whether or not separately listed on Schedule A. Every requirement, restriction, representation, covenant, Closing condition and remedy concerning Key Personal IP Partners, their IP rights, agreements or revenue applies equally to Seller in his personal capacity, all Seller Personal IP and the IP Cooperation Agreement, as applicable. No removal or narrowing of a Key Personal IP Partner or the covered rights is effective without Buyer’s express written agreement under Sections 8.04 and 11.06. Notwithstanding any broader wording elsewhere in this Agreement, the IP rights, revenue and other economic benefits of a Key Personal IP Partner other than Seller covered by this Agreement are limited to those arising under or within the scope of that partner’s applicable cooperation agreement, as amended in accordance with this Agreement; this limitation does not apply to Seller Personal IP or its related rights, revenue and economic benefits.
3
“Knowledge of Seller” means the actual knowledge of Seller after reasonable inquiry of the officers and employees of the Company responsible for the relevant matter.
“Law” means any applicable statute, rule, regulation, listing rule, order or other requirement of a Governmental Authority.
“Losses” means losses, damages, liabilities, deficiencies, judgments, settlements, interest, penalties, Taxes and reasonable out-of-pocket professional fees and expenses.
“Material Adverse Effect” means any event, change or circumstance that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on the Business, assets, liabilities, results of operations or financial condition of the Company, or on Seller’s or the Company’s ability to consummate the transactions, excluding general economic, market or industry conditions except to the extent disproportionately affecting the Company.
“Nasdaq” means The Nasdaq Stock Market LLC.
“Nasdaq Rules” means all applicable rules of Nasdaq, including Rules 5110(a), 5250, 5602, 5605, 5630 and 5635.
“Personal IP Partner” means a creator, key opinion leader, celebrity, professional, expert or other person whose identity, content, audience or commercial rights are operated or monetized by the Company.
“Person” means an individual, corporation, partnership, limited liability company, trust, association, governmental authority or other entity.
“Pre-Closing Restructuring” means the lawful vesting, directly or indirectly, in the Company of (i) all rights, interests and economic benefits relating to Seller Personal IP, including all commercialization rights, revenue and receivables, and (ii) all cooperation agreements with the Key Personal IP Partners other than Seller and all related rights, interests, revenue and economic benefits under those agreements, in each case including those owned, controlled or held by Seller, the Company or any of their respective Affiliates, and all other material Personal IP Partner agreements and related operating assets, together with the execution of the IP Cooperation Agreement covering all Seller Personal IP and binding agreements with all other Key Personal IP Partners. Such vesting shall be effected by valid and enforceable written assignments, novations, transfers, licenses, consents or other lawful arrangements approved by Buyer in writing, so that, by Closing, the Company has exclusive commercialization and revenue-collection rights, free of Encumbrances and conflicting rights, in respect of the covered rights and economic interests. Transferable ownership rights in Seller Personal IP shall be assigned to the Company unless Buyer approves an alternative arrangement in writing. Any indirect arrangement must give the Company effective control of the covered rights and their proceeds and direct contractual enforcement rights against each relevant rights holder and intermediary. Rights that cannot lawfully be transferred, including non-transferable personality or moral rights, shall be addressed through lawful exclusive commercialization permissions with a defined scope and term approved by Buyer, and arrangements securing the related economic benefits for the Company, without overriding non-waivable mandatory Law. The Pre-Closing Restructuring shall comply with all applicable Laws, and all required consents and the exclusive commercialization and full revenue rights required by Sections 6.20, 8.03 and 8.08 shall be effective in favor of the Company no later than Closing.
4
“Reference Price” means US$6.25 per Consideration Share, being the fixed agreed issue price and contractual value per share, subject only to the mechanical recapitalization adjustment in Section 3.02(a).
“Reversal Completion” has the meaning set forth in Section 9.08(c).
“SEC” means the U.S. Securities and Exchange Commission.
“Securities Act” means the U.S. Securities Act of 1933, as amended.
“Subsidiary” means with respect to a Person, any entity of which that Person owns or controls more than fifty percent of the voting power or economic interests.
“Wholly Owned Subsidiary” means an entity one hundred percent (100%) of whose outstanding equity and economic interests are owned, directly or indirectly, by Buyer. An entity merely controlled by Buyer, consolidated through contractual arrangements or partly owned by an unrelated Person does not qualify.
“Tax” means any tax, levy, duty, assessment, withholding or similar governmental charge, together with interest and penalties.
“Transaction Documents” means this Agreement and the Ancillary Documents.
Section 1.02 Interpretation.
Unless the context otherwise requires: (a) “including” means “including without limitation”; (b) words in the singular include the plural and vice versa; (c) references to Articles, Sections and Schedules are to this Agreement; (d) references to any Law or Contract include amendments and successors; (e) “or” is not exclusive; (f) “US$” and “dollars” refer to U.S. dollars; and (g) the headings are for convenience only. This Agreement will be construed without any presumption against the drafting Party.
ARTICLE II
Purchase and Sale
Section 2.01 Sale and Purchase of Purchased Shares.
Subject to the terms and conditions of this Agreement, at the Closing Seller shall sell, assign, transfer and deliver to Buyer, and Buyer shall purchase and acquire from Seller, all of the Purchased Shares, free and clear of all Encumbrances, together with all rights attaching to them at and after Closing.
5
Section 2.02 No Assumption of Seller Liabilities.
Buyer does not assume any liability of Seller by acquiring the Purchased Shares. The Company will retain its liabilities as a matter of Law, subject to Seller’s representations, covenants and indemnification obligations under this Agreement.
Section 2.03 Further Assurances.
Each Party shall execute and deliver further instruments and take further actions reasonably necessary to vest title to the Purchased Shares in Buyer and give effect to the transactions contemplated by this Agreement.
ARTICLE III
Purchase Price and Consideration Shares
Section 3.01 Purchase Price.
The agreed equity valuation of the Company and the purchase price for all of the Purchased Shares (the “Purchase Price”) are US$8 million. The Purchase Price shall be satisfied in full by the issuance at Closing of 1,280,000 shares of AIFA Common Stock, representing approximately 19.94% of Buyer’s issued and outstanding AIFA Common Stock as of the Execution Date, to Seller (the “Total Consideration Shares”) at the Reference Price of US$6.25 per share.
Section 3.02 Share Adjustments and Issuance Requirements.
| (a) | If Buyer effects a stock split, reverse split, combination, reclassification, share dividend or similar recapitalization before Closing, the share basis and the Reference Price shall be adjusted proportionately to preserve the agreed economic result without double counting. No other market-price reset applies. Any transaction change must satisfy Section 5.01(d). |
| (b) | Buyer shall use commercially reasonable efforts to obtain the stockholder approval and complete the other pre-issuance requirements under Sections 5.01(d) and 8.09. The issuance shall be within the terms and scope of the approvals so obtained. |
Section 3.03 Issuance of Consideration Shares at Closing.
At Closing, subject to the satisfaction or waiver of the conditions set forth in Article V, Buyer shall issue to Seller all of the Total Consideration Shares in book-entry form through Buyer’s transfer agent. The Consideration Shares shall be deemed issued as of the Closing Date, and no portion of the Consideration Shares shall be deferred or issued in installments; the Consideration Shares are, however, held subject to the escrow and lock-up in Section 3.05 and the surrender rights in Section 9.08.
6
Section 3.04 Issuance Mechanics and Investment Representations.
| (a) | The Consideration Shares will be validly issued, fully paid and non-assessable when issued at Closing, and will carry the voting and economic rights generally applicable to AIFA Common Stock from the Closing Date, subject to transfer restrictions under this Agreement and applicable Law. |
| (b) | The Consideration Shares have not been registered under the Securities Act or state securities Laws and are issued in reliance on Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D. Seller shall deliver all investor questionnaires, tax forms and supporting documents reasonably requested by Buyer or its transfer agent. |
| (c) | Seller is acquiring the Consideration Shares for investment for Seller’s own account and not with a present view to an unlawful distribution; has sufficient financial and business knowledge to evaluate the investment; has had access to Buyer’s SEC filings and an opportunity to ask questions; and understands the speculative nature, transfer restrictions and risk of loss associated with the Consideration Shares. |
| (d) | Seller shall represent in the applicable investor questionnaire whether Seller is an accredited investor under Rule 501(a) of Regulation D and that no disqualifying event under Rule 506(d) applies to him. The specific exemption and legends will be determined by Buyer and its U.S. securities counsel based on those representations. |
Section 3.05 Lock-Up.
Until the later of (i) twelve months after Closing and (ii) if a notice under Section 9.08(c) is then pending, its final resolution, Seller shall not sell, transfer, pledge, hedge or otherwise dispose of Consideration Shares, except a transfer approved in writing by Buyer to an Affiliate or estate-planning vehicle that joins the same restrictions and the surrender obligations in Sections 9.07 and 9.08. At Closing, all Total Consideration Shares shall be issued in book-entry form into a restricted escrow or transfer-agent hold account in Seller’s name under an escrow agreement in form reasonably satisfactory to Buyer, and released to Seller only at the end of that period; provided that Consideration Shares with a value determined under Section 9.07(b) equal to the aggregate amount claimed in all indemnification claims under Article IX that have been notified in writing and remain unresolved at the end of that period shall remain in escrow, and shall be released to Buyer for cancellation or to Seller, as applicable, within five (5) Business Days after the final resolution of each such claim by written agreement or final enforceable determination. While Consideration Shares are held in escrow, and except as provided in Section 9.08(c), Seller may exercise the voting rights attached to them and shall receive ordinary cash dividends paid on them; all other dividends and distributions on them, including any securities issued on a split, recapitalization or reclassification, shall be deposited into escrow and held and released on the same terms as the Consideration Shares to which they relate. Buyer may place appropriate legends and stop-transfer instructions. Expiry of this lock-up does not discharge accrued or continuing surrender, reciprocal retransfer or cash liabilities under Section 9.08; a pending claim is subject to the targeted preservation mechanism in Section 9.08(c).
Section 3.06 Taxes and Withholding.
Each Party is responsible for Taxes imposed on its income, gains or receipts from the transactions. Buyer may deduct and withhold amounts required by Law; amounts timely remitted will be treated as paid to the Person from whom withheld. The Parties shall reasonably cooperate to minimize withholding where permitted by Law.
7
ARTICLE IV
Closing
Section 4.01 Closing Generally.
The Closing will occur remotely by electronic exchange of signatures and documents on the third Business Day after all conditions in Article V have been satisfied or waived, or on another date agreed in writing. All Closing actions will be deemed simultaneous.
Section 4.02 Seller and Company Closing Deliverables.
| (a) | stock certificates, if any, representing the Purchased Shares, duly endorsed or accompanied by executed stock powers, and an updated stock ledger showing Buyer as owner of all outstanding shares; |
| (b) | certificates of good standing and certified organizational documents of the Company; |
| (c) | resolutions approving the Transaction Documents and the transactions contemplated by them; |
| (d) | evidence reasonably satisfactory to Buyer that Seller and the Company have completed the Pre-Closing Restructuring in compliance with all applicable Laws, including executed copies of all cooperation agreements relating to Seller Personal IP and with all Key Personal IP Partners and all assignments, novations, licenses and other Pre-Closing Restructuring documents and binding agreements and undertakings from every Key Personal IP Partner, including Seller in his personal capacity in respect of all Seller Personal IP, directly or indirectly vesting in the Company the rights and economic benefits comprised in the Pre-Closing Restructuring, including the applicable revenue entitlements under Sections 6.20 and 8.08, together with all necessary consents and payment directions and evidence of the chain of title or authority and the effectiveness of any indirect arrangement; |
| (e) | the IP Cooperation Agreement covering all Seller Personal IP, duly executed by Seller in his personal capacity and the Company and in full force and effect at Closing, in form and substance reasonably satisfactory to Buyer, and each other Ancillary Document to which Seller or the Company is a party; |
| (f) | PCAOB-audited financial statements, required interim financial statements, supporting records and auditor cooperation sufficient for Buyer to satisfy the applicable SEC acquired-business and pro forma reporting requirements; |
| (g) | releases of all Encumbrances over the Purchased Shares and material Company assets (if applicable); |
| (h) | an officer’s certificate confirming satisfaction of the conditions in Section 5.01; |
| (i) | the final Schedule A and Disclosure Schedules accepted under Section 6.19; and |
| (j) | the surrender, retransfer and implementation instruments and undertakings required by Section 9.08, in a form accepted by the relevant transfer agent or registrar and consistent with applicable Law. |
8
Section 4.03 Buyer Closing Deliverables.
| (a) | evidence from Buyer’s transfer agent of book-entry issuance of all of the Consideration Shares to Seller; |
| (b) | certified copies of resolutions of Buyer’s board and Special Committee authorizing the final transaction terms and issuance; |
| (c) | evidence of the stockholder approval required by Section 5.01(d), which may consist of Buyer’s public disclosure of the voting results; |
| (d) | the regulatory closing file required by Section 8.09; |
| (e) | the Ancillary Documents to which Buyer is a party, including the undertakings and conditional instructions necessary to implement the simultaneous share surrender and return of the Company under Section 9.08; and |
| (f) | an officer’s certificate confirming satisfaction of the conditions in Section 5.02. |
ARTICLE V
Conditions Precedent
Section 5.01 Conditions to Buyer Obligations.
Buyer’s obligation to close is subject to the following conditions, which Buyer may waive in writing only to the extent legally waivable. Section 5.01(d) and any other condition embodying a mandatory legal or regulatory requirement may not be waived:
| (a) | Buyer has completed legal, financial, tax, commercial, technology and operational due diligence of the Company to Buyer’s reasonable satisfaction; |
| (b) | the Fundamental Representations are true and correct in all respects, and all other representations of Seller and the Company are true and correct in all material respects (disregarding any materiality or Material Adverse Effect qualifier), in each case at the Execution Date and at Closing as if made at Closing, and Seller and the Company have performed their covenants; |
| (c) | the Special Committee has completed its independent review, received full disclosure of conflicts and approved the final transaction terms; Buyer’s board has duly authorized the issuance and Closing with Seller recused, and the independent review and governance procedures in Section 8.09(a) have been completed; |
9
| (d) | Buyer has obtained (i) the stockholder approval required by Nasdaq Rule 5635(a)(2) and any other applicable rule and (ii) the approval of the holders of a majority of the outstanding shares of AIFA Common Stock not owned, directly or indirectly, by Seller, his Affiliates or any other Person with a material interest in the transactions contemplated hereby; Buyer has filed the Listing of Additional Shares notification required by Section 8.09(b), and Nasdaq has not objected to the issuance or notified Buyer of any unresolved deficiency relating to it before the end of the applicable notification period; |
| (e) | the Special Committee has received a written opinion of an independent financial adviser selected by it that, as of its date, the consideration payable by Buyer is fair, from a financial point of view, to Buyer and its stockholders other than Seller, together with such other financial advice and valuation analysis as the Special Committee considers appropriate in discharging its duties; |
| (f) | Buyer has received the financial statements described in Section 4.02(f) and, no later than ten (10) Business Days before the anticipated Closing Date, the complete Schedule A and Disclosure Schedules, in each case in form and substance satisfactory to Buyer in its sole discretion; |
| (g) | Seller and the Company have completed the Pre-Closing Restructuring in compliance with all applicable Laws and to Buyer’s reasonable satisfaction, and Buyer has received the evidence and documents required by Section 4.02(d); |
| (h) | Seller in his personal capacity and the Company have duly executed the IP Cooperation Agreement covering all Seller Personal IP, and the Company has entered into binding agreements and undertakings with every other Key Personal IP Partner, in each case in form and substance approved in writing by Buyer pursuant to Section 8.03. All such instruments are enforceable and in full force and effect, grant the Company the exclusive commercialization and full revenue rights required by Sections 6.20, 8.03 and 8.08, and have all necessary consents, licenses, payment directions, account-control, reporting and enforcement arrangements operational at Closing. Seller Personal IP is subject to the same requirements and restrictions as the IP of all other Key Personal IP Partners; |
| (i) | if Nasdaq Rule 5110(a) applies, Buyer has obtained Nasdaq’s approval of the required initial listing application before consummation; any related control, governance and listing issues have been resolved under Section 5.01(d); |
| (j) | all required governmental, regulatory and material third-party approvals, consents, filings and waivers have been obtained; |
| (k) | no Material Adverse Effect has occurred; |
| (l) | the IP Cooperation Agreement covering all Seller Personal IP and each other Key Personal IP Partner agreement remains valid and in full force and effect, and none has been terminated, waived or materially adversely amended in connection with the transaction; |
| (m) | AIFA Common Stock remains listed on the Nasdaq Capital Market, and the issuance complies with applicable Law and Nasdaq Rules; |
| (n) | no Law or order prohibits the Closing, and all notifications, filings, clearances and waiting periods required under applicable Law have been made, obtained or expired, including, if applicable, under (i) CFIUS (Section 721 of the Defense Production Act and 31 C.F.R. Parts 800–802), and (ii) the DOJ data security rule (28 C.F.R. Part 202) and the Protecting Americans’ Data from Foreign Adversaries Act of 2024. |
10
Section 5.02 Conditions to Seller Obligations.
Seller’s obligation to close is subject to satisfaction or written waiver by Seller of the following conditions:
(a) Buyer’s representations are true and correct at Closing, subject to customary materiality standards;
(b) Buyer has performed its covenants;
(c) Buyer has completed the corporate, regulatory and issuance processes in Sections 5.01(d) and 8.09 necessary to lawfully issue the Consideration Shares;
(d) AIFA Common Stock remains listed on the Nasdaq Capital Market; and
(e) no Law or order prohibits the Closing.
ARTICLE VI
Representations and Warranties of Seller and the Company
Except as disclosed in the schedules delivered by Seller and the Company to Buyer in accordance with Section 6.19 (the “Disclosure Schedules”), Seller and the Company jointly and severally represent and warrant to Buyer as of the Execution Date and Closing as follows. From and after Closing, Seller alone shall be liable for any inaccuracy in or breach of these representations and warranties and of any pre-Closing covenant of the Company, and neither the Company nor Buyer or any of its Subsidiaries shall have any liability for them. Seller irrevocably waives, effective at Closing, any right of contribution, indemnification, subrogation, reimbursement or advancement against the Company, and any claim that Buyer’s knowledge or the Company’s knowledge, conduct or records reduces Seller’s liability, in each case relating to these representations and warranties or the transactions contemplated hereby:
Section 6.01 Organization and Qualification.
The Company is duly incorporated, validly existing and in good standing under the laws of the State of California and has power to own its assets and conduct the Business. Each Subsidiary is duly organized and qualified where required. Schedule 6.03 lists each Subsidiary of the Company and its issued equity, all of which is owned by the Company free and clear of all Encumbrances, has been validly issued and is not subject to any option, warrant, conversion or other right to acquire equity. If no Subsidiary is listed, the Company has no Subsidiary and holds no equity interest in any other Person.
11
Section 6.02 Authority and Enforceability.
Seller has capacity, and the Company has corporate power and authorization, to execute and perform the Transaction Documents. Each Transaction Document constitutes a valid and binding obligation, subject to bankruptcy and equitable principles.
Seller has fully disclosed to Buyer’s board of directors and the Special Committee all material facts concerning Seller’s direct and indirect interests in the Company, the Purchased Shares, the Purchase Price, the Consideration Shares and the transactions contemplated by this Agreement. Seller has not participated, and will not participate, in any vote of Buyer’s board or any board committee approving this Agreement or the transactions, except to the extent expressly requested solely to provide factual information, and Seller has complied with Buyer’s code of conduct, related-party transaction policy and applicable conflict-of-interest requirements.
Section 6.03 Capitalization and Title.
The Purchased Shares constitute all of the issued and outstanding equity securities of the Company. All Purchased Shares have been duly authorized and validly issued, are fully paid and non-assessable, were issued in compliance with applicable Law and the Company’s organizational documents, and were not issued in violation of any preemptive right, right of first refusal, purchase option or similar right. Seller is the sole record and beneficial owner of, and has good and valid title to, all of the Purchased Shares, free and clear of all Encumbrances, and has full right, power and authority to sell, assign and transfer them to Buyer. Seller does not hold any Purchased Shares as nominee, trustee or agent for, or under any declaration of trust, entrustment, proxy or other arrangement with, any other Person. No option, warrant, convertible or exchangeable security, profits interest, phantom equity, stock appreciation right, equity-based compensation, subscription, call, commitment, voting trust, voting agreement, proxy or other right or Contract is outstanding that (a) obligates the Company or Seller to issue, sell, transfer, redeem or repurchase any equity of the Company, (b) relates to the voting or transfer of any equity of the Company, or (c) entitles any Person to any portion of the profits, revenue or value of the Company. No Person has made any claim that it is entitled to any equity interest in the Company. Upon delivery of the Purchased Shares, Buyer will acquire good and valid title to one hundred percent (100%) of the issued and outstanding equity of the Company, free and clear of all Encumbrances other than those created by Buyer.
Section 6.04 No Conflicts and Consents.
Execution and performance of this Agreement do not violate organizational documents, applicable Law or any material Contract, or result in an Encumbrance, except for approvals listed on Schedule 6.04.
12
Section 6.05 Financial Statements.
The financial statements delivered to Buyer fairly present, in all material respects, the financial condition and results of the Company and its subsidiaries in accordance with the stated accounting basis. The Company has no material liabilities except those reflected or reserved, incurred in the ordinary course, or disclosed on Schedule 6.05.
Section 6.06 Compliance and Permits.
The Company has complied in all material respects with applicable Laws and holds all material permits required for the Business. No material violation notice remains unresolved.
Section 6.07 Material Contracts and Personal IP Partners.
Schedule 6.07 lists each material Contract, including the IP Cooperation Agreement covering all Seller Personal IP and every other Key Personal IP Partner agreement. Each executed Contract is valid and enforceable, the Company and Seller are not in material default of their respective obligations, and no counterparty has given notice of termination or material default. Neither Seller nor the Company has promised undisclosed revenue shares, minimum guarantees, equity, account ownership or termination payments relating to those arrangements.
Section 6.08 Intellectual Property and Digital Assets.
The Company exclusively owns, free and clear of all Encumbrances, or has valid, enforceable, sufficient and, to the extent required by Section 8.08(b), transferable rights to use, all Company Intellectual Property, which together constitute all Intellectual Property necessary and sufficient to conduct the Business as currently conducted and as conducted at Closing. Schedule 6.08 completely and accurately identifies all registered and applied-for Company Intellectual Property, all material licensed rights (and the licensor and term of each), and all domains, social-media handles, platform accounts and administrative credentials used in the Business, together with the registered holder of each. Each registered item is subsisting, valid and enforceable, and all registration, renewal and maintenance fees due on or before Closing have been paid. Each such domain, handle and platform account is registered in the name of, and is under the sole administrative control of, the Company, except as specifically disclosed on Schedule 6.08 together with the lawful arrangement required by Section 8.08(d). Neither the Company nor the conduct of the Business has infringed, misappropriated or otherwise violated, or currently infringes, misappropriates or otherwise violates, the Intellectual Property, publicity or personality rights of any Person. No claim, demand, takedown notice, platform strike or proceeding is pending or, to the Knowledge of Seller, threatened alleging any such violation or challenging the ownership, validity, enforceability or use of any Company Intellectual Property. To the Knowledge of Seller, no Person is infringing any Company Intellectual Property. Each current and former employee, contractor, Personal IP Partner and other Person who created or contributed to any Company Intellectual Property has validly and irrevocably assigned all of its rights in that contribution to the Company, or granted the Company an exclusive license sufficient for the Business, and has waived any moral rights to the extent permitted by Law. No such Person, including Seller or any of his Affiliates, retains any right, title, interest or claim to compensation in or to any Company Intellectual Property other than as expressly set forth in the IP Cooperation Agreement or a Key Personal IP Partner agreement listed on Schedule 6.07. The Company controls, and at Closing will have exclusive possession and control of, the accounts, credentials, content libraries, source materials and audience data used in the Business, subject only to disclosed platform terms, the IP Cooperation Agreement covering Seller Personal IP and the other Personal IP Partner agreements. The execution of this Agreement and the consummation of the Pre-Closing Restructuring and the Closing will not result in the loss, impairment, termination or suspension of, or any payment obligation or consent requirement with respect to, any Company Intellectual Property, platform account or monetization right.
13
Seller is the sole and exclusive legal and beneficial owner of, or otherwise exclusively controls, all Seller Personal IP, free and clear of any Encumbrance. No other Person, including any Affiliate of Seller, any management, talent or multi-channel network agency or any platform, holds any right, title or interest in or to any Seller Personal IP or any revenue from it. Seller has not made and will not make any assignment, license, option, grant, commitment, endorsement or exclusivity undertaking, or any other arrangement, that conflicts with, limits, is senior to or would prevent the full performance of the IP Cooperation Agreement. Every prior arrangement of that kind has been validly terminated or novated to the Company, without continuing liability to the Company, as part of the Pre-Closing Restructuring. No Person has asserted or, to the Knowledge of Seller, threatened any claim challenging Seller’s ownership or control of any Seller Personal IP, and no fact or circumstance exists that would reasonably be expected to give rise to such a claim. Seller has not done or omitted to do anything that has damaged or would reasonably be expected to materially damage the reputation, goodwill or commercial value of the Seller Personal IP.
Upon execution and delivery, the IP Cooperation Agreement will constitute a legal, valid and binding obligation of Seller in his personal capacity and the Company, enforceable in accordance with its terms. It will grant the Company the exclusive, worldwide, sublicensable commercialization rights and full revenue entitlement for all Seller Personal IP required by Sections 6.20 and 8.08. It will permit lawful post-Closing transfers of the relevant rights and obligations to Buyer or another Wholly Owned Subsidiary in accordance with Section 8.08(b), without further consent of or payment to Seller. It will not be terminable by Seller, and will not terminate or lapse because Seller ceases to be a director, officer or employee of Buyer, other than upon Reversal Completion under Section 9.08(f). No consideration, royalty or other payment is or will be payable to Seller or any of his Affiliates under it, other than the Consideration Shares. At Closing the IP Cooperation Agreement will be in full force and effect without any amendment, waiver, side letter, termination or breach inconsistent with this Agreement. The Pre-Closing Restructuring will have been fully and validly completed, with all required consents, novations, payment directions and platform transfers effective, so that the Company holds at Closing all rights and revenue entitlements described in this Section 6.08 and Section 6.20.
Section 6.09 Content Rights and Publicity Rights.
The Company has obtained all material consents, releases and licenses required to produce, edit, distribute and monetize content and to use the names, images, likenesses, voices, biographies and other publicity rights of Personal IP Partners and featured persons, expressly including Seller in his personal capacity and all Seller Personal IP. No content has been generated, acquired or used in a manner that materially violates applicable copyright, advertising, consumer-protection or platform rules.
14
Section 6.10 Data Privacy and Cybersecurity.
The Company has complied in all material respects with applicable privacy and data-security Laws, platform requirements and published policies. It maintains commercially reasonable safeguards, and no material security incident, unauthorized access or reportable data breach has occurred except as disclosed on Schedule 6.10.
Section 6.11 Followers Traffic and Metrics.
The audience, follower, engagement, traffic, conversion and revenue data supplied to Buyer are accurate and complete in all material respects and were derived from the Company’s records and applicable platform analytics. Neither the Company, Seller nor, to the Knowledge of Seller, any Key Personal IP Partner has used bots, click farms, purchased followers, fabricated engagement, undisclosed paid traffic or other deceptive means to inflate those metrics, and no platform has suspended, restricted, demonetized or penalized any material account for such conduct.
Section 6.12 Advertising Ecommerce and Consumer Matters.
The Company has complied in all material respects with Laws governing advertising disclosures, endorsements, promotions, e-commerce, consumer rights, refunds and product claims. No Company content knowingly contains materially false or misleading claims.
Section 6.13 Employment and Contractors.
Schedule 6.13 lists key employees and contractors and material compensation arrangements. The Company has complied in all material respects with employment, wage, benefit and independent-contractor Laws, and no material labor dispute is pending or threatened.
Section 6.14 Taxes.
The Company has timely filed all material Tax returns and paid all material Taxes due. No material audit, dispute, lien or unpaid withholding exists except as disclosed. The Company has not been a party to a tax allocation agreement or transaction intended primarily to avoid Tax.
15
Section 6.15 Litigation.
No material Action is pending or, to the Knowledge of Seller, threatened against Seller, the Company, the Business or the Purchased Shares, and no order materially restricts the Business or the transaction.
Section 6.16 Anti-Corruption Sanctions and AML.
Neither Seller, the Company nor, to the Knowledge of Seller, any director, officer, employee, Personal IP Partner or agent acting on their behalf has, in the past five (5) years, violated applicable anti-bribery (including the U.S. Foreign Corrupt Practices Act), anti-money-laundering, sanctions or export-control Laws, or been the subject of any related investigation, inquiry or enforcement action. Neither Seller nor the Company is, or is owned or controlled by, or acts on behalf of, a sanctioned person, and neither has dealt with or for the benefit of any sanctioned person or sanctioned country. The Company maintains policies and procedures reasonably designed to ensure compliance with these Laws.
Section 6.17 Related-Party Transactions.
Schedule 6.17 lists all material transactions and balances between the Company, on one hand, and Seller or any Affiliate, director, officer, employee or Personal IP Partner, on the other. No undisclosed related-party liability will remain after Closing.
Section 6.18 Full Disclosure.
No representation in this Agreement or certificate delivered under it contains an untrue statement of material fact or omits a material fact necessary to make the statements made, in light of the circumstances, not misleading.
Section 6.19 Delivery and Effect of Schedule A and Disclosure Schedules.
(a) Seller and the Company shall deliver a complete Schedule A and complete Disclosure Schedules to Buyer as soon as practicable after the Execution Date and in any event no later than ten (10) Business Days before the anticipated Closing Date. Each disclosure shall identify the applicable Section of this Agreement and describe the disclosed matter in reasonable detail. Schedule A and the Disclosure Schedules will become part of this Agreement when accepted in writing by Buyer, in its sole discretion, and no further amendment to this Agreement will be required.
(b) A Disclosure Schedule delivered after the Execution Date does not qualify any representation or warranty made as of the Execution Date, cure any breach existing on or before the Execution Date, or limit any right or remedy of Buyer, unless Buyer expressly agrees otherwise in writing. A Disclosure Schedule accepted by Buyer may qualify a representation or warranty made as of Closing only to the extent expressly stated in Buyer’s written acceptance.
(c) Seller and the Company shall promptly update Schedule A and the Disclosure Schedules through Closing to reflect any material change. No update is effective unless accepted in writing by Buyer, and no update cures a breach or limits Buyer’s rights or remedies unless Buyer expressly agrees otherwise in writing.
16
Section 6.20 Seller Personal IP and Key Personal IP Partner Revenue.
(a) Seller and the Company represent and warrant, as of the Execution Date and as of Closing, that all existing grants, payment instructions, revenue-sharing arrangements, side letters and restrictions affecting Seller Personal IP or revenue generated by any Key Personal IP Partner have been fully and accurately disclosed to Buyer in writing (which need not be in a completed Schedule A as of the Execution Date), that no undisclosed arrangement conflicts with the revenue entitlements and restrictions in Section 8.08, and that no Key Personal IP Partner or other Person has received or is entitled to any undisclosed payment, rebate or other benefit in connection with those arrangements or the transactions. All such matters shall be fully and accurately included in Schedule A delivered to and accepted in writing by Buyer in accordance with Section 6.19. As of Closing, they further represent and warrant that Seller in his personal capacity has executed the IP Cooperation Agreement with the Company covering all Seller Personal IP, and every other Key Personal IP Partner has entered into binding, enforceable instruments with the Company sufficient to vest in the Company the full entitlement to all direct and indirect revenue, income, receipts and economic benefits generated by or attributable to Seller Personal IP and each Key Personal IP Partner from and after Closing, on the terms of Section 8.08, that all platform payment directions and settlement accounts for that revenue are in the Company’s name and under its control, and that conflicting arrangements have been validly terminated or novated without continuing liability to the Company.
(b) Subject to Section 9.08(f), Seller and the Company further undertake on a continuing basis from Closing that all such revenue, expressly including all revenue from Seller Personal IP, shall belong to and be paid to Buyer or a Wholly Owned Subsidiary in accordance with Section 8.08(b), and shall not be booked as revenue of, paid for the benefit of or retained by Seller, a partner or any other Person outside Buyer and its Wholly Owned Subsidiaries. Seller shall procure each Key Personal IP Partner’s compliance through the executed undertakings and payment-control arrangements and shall remain contractually responsible to Buyer for a failure of that undertaking, whether or not the partner is Seller’s controlled Affiliate. This promise is not limited to revenue from contracts, channels or territories existing at Closing or to a narrower license description in an Ancillary Document, and extends to Seller Personal IP created or acquired after Closing. Seller shall not, directly or indirectly, avoid it by using new entities, accounts, channels, nominees or personas, by shifting value into non-cash or deferred compensation, or by accepting below-market terms for the Company in exchange for benefits to Seller or his Affiliates.
(c) Any prohibited receipt, retention, diversion or attribution of such revenue is a material breach that entitles Buyer, at its election under Section 9.08, to require surrender and cancellation of all Consideration Shares concurrently with Buyer’s return of all equity in the Company to Seller, together with remittance and additional compensation for Losses, on the terms of Section 9.08. The number of shares to be surrendered is not determined by the amount of revenue or Losses. This continuing undertaking survives Closing and is not cut off by the eighteen-month survival period for ordinary representations, subject to the prospective cessation and accrued-rights provisions in Section 9.08(f). No disclosure, contractual expiry, partner substitution or transfer within Buyer’s group permits income to leave the permitted recipient group unless Buyer expressly amends these obligations in writing under Sections 8.04 and 11.06. Seller is not liable solely for a disposition of revenue expressly directed by Buyer in accordance with this Agreement or an independent wrongful act of Buyer that Seller and the partners neither caused nor assisted.
17
Section 6.21 Brokers.
No broker, finder, investment banker, agent or other intermediary has acted for Seller, the Company or any of their Affiliates in connection with the transactions, and no such Person is or will be entitled to any brokerage, finder’s, success or similar fee or commission, in cash or equity, based on arrangements made by or on behalf of Seller, the Company or their Affiliates. Seller alone shall bear any such fee or commission.
ARTICLE VII
Representations and Warranties of Buyer
Section 7.01 Organization Authority and Enforceability.
Buyer is duly incorporated, validly existing and in good standing under Delaware Law. Buyer has corporate power and has obtained the corporate authorization necessary to execute and deliver this Agreement as a binding obligation on the Execution Date, subject to customary bankruptcy and equitable principles.
Section 7.02 No Conflicts and Consents.
Execution and performance do not violate Buyer’s organizational documents or any material Contract. Performance and issuance remain subject to the regulatory processes expressly described in Articles III and V and Section 8.09. No representation is made that a contractual issuance percentage or price itself establishes an exemption from applicable Law or Nasdaq Rules.
Section 7.03 Authorization of Consideration Shares.
Buyer shall duly authorize the Consideration Shares before Closing. When issued in compliance with this Agreement and applicable Law, they will be validly issued, fully paid and non-assessable, subject to the contractual surrender obligations and applicable transfer restrictions.
Section 7.04 Listing and Litigation.
AIFA Common Stock is listed on the Nasdaq Capital Market. No Action is pending or, to Buyer’s knowledge, threatened that would reasonably be expected to prevent Buyer from consummating the transactions.
18
ARTICLE VIII
Covenants
Section 8.01 Conduct of Business Before Closing.
From the Execution Date until Closing, Seller shall cause the Company to operate the Business in the ordinary course, preserve relationships with Key Personal IP Partners and employees and all rights in Seller Personal IP, maintain its permits and assets, and not, without Buyer’s prior written consent, issue equity, incur material debt, transfer material assets, amend, waive or terminate the IP Cooperation Agreement or any other Key Personal IP Partner agreement, grant conflicting rights in Seller Personal IP or any other covered IP, enter a material related-party transaction, make an unusual distribution, settle material litigation or take any action reasonably expected to impair the Closing.
Section 8.02 Access and Due Diligence.
Subject to applicable Law and confidentiality duties, Seller and the Company shall provide Buyer and its representatives reasonable access to personnel, records, contracts, platform analytics, account-control evidence and other information reasonably requested for diligence, financing, audit, SEC or Nasdaq purposes.
Section 8.03 Pre-Closing Restructuring.
As an obligation of Seller to be performed before Closing, Seller shall, and shall cause the Company and their respective Affiliates to, complete the Pre-Closing Restructuring at Seller’s and the Company’s cost, in compliance with all applicable Laws and in a manner satisfactory to Buyer. By Closing, the Company shall have obtained the rights and economic benefits comprised in the Pre-Closing Restructuring, with the required commercialization, collection and enforcement arrangements effective and operational. Seller shall deliver the evidence and documents required by Section 4.02(d) at Closing. Approval of an indirect arrangement shall not, of itself, release Seller from his obligations under this Agreement. The Company shall be the sole beneficiary of the covered IP commercialization and revenue rights before Closing, whether held directly or through lawful indirect arrangements satisfactory to Buyer. As part of the Pre-Closing Restructuring, Seller shall expressly vest in the Company under the IP Cooperation Agreement the sole and exclusive worldwide entitlement to all present and future direct and indirect revenue and commercial or economic benefits arising from Seller Personal IP, including IP created or acquired after Closing, without reserving any such entitlement for himself or his Affiliates and through the lawful arrangements specified in the definition of Pre-Closing Restructuring. Seller shall personally execute the IP Cooperation Agreement with the Company covering all Seller Personal IP, and Seller and the Company shall obtain binding agreements, novations, consents, licenses and payment directions from every other Key Personal IP Partner, conferring on the Company the rights and revenue entitlements required by Sections 6.20 and 8.08. All required legal, tax, accounting and platform formalities shall be completed no later than Closing. Any indirect arrangement shall enable the Company to collect the covered revenue and enforce the covered rights in its own name without further consent or cooperation from Seller or his Affiliates, supported by binding undertakings and all necessary consents and payment directions. Before Closing, Buyer shall have approved in writing each other Key Personal IP Partner’s cooperation agreement, including its scope of rights and revenue, term, termination rights and exclusions; each agreement must cover existing and future exploitation of the covered IP across channels and platforms and prohibit diversion through new entities or arrangements.
19
The IP Cooperation Agreement covering all Seller Personal IP and all other Key Personal IP Partner agreements and undertakings shall be effective no later than Closing and subject to the same performance, compliance and enforcement requirements. Seller and the Company shall fully perform and enforce them, subject after Closing to lawful transfers within Buyer and its Wholly Owned Subsidiaries under Section 8.08(b). They may not narrow the covered revenue or Buyer’s remedies, or amend, waive, terminate or grant conflicting rights without Buyer’s express written consent through the independent body under Section 8.04. No expiry or termination of an ancillary license or partner agreement alone releases the continuing revenue undertaking in this Agreement or accrued collection and remittance rights; an agreed release must expressly identify the affected obligation. Section 9.08(f) expressly governs the return of rights and the cessation of future revenue obligations upon Reversal Completion and prevails over this Section to that extent. The relevant Ancillary Documents shall provide for that return and transition, subject to necessary third-party consents and applicable Law.
Section 8.04 Regulatory and SEC Cooperation.
The Parties shall cooperate in good faith with the SEC and Nasdaq processes and the pre-Closing steps in Section 8.09. Buyer controls its public filings and regulatory communications, giving Seller a reasonable opportunity to review factual descriptions of him and the Company where practicable. No provision requires a director or committee to act contrary to fiduciary duties or applicable Law, or permits an issuance prohibited by applicable requirements.
Seller shall provide accurate and complete information for related-person disclosure under Item 404 of Regulation S-K, Section 16 reports and beneficial-ownership reporting, including his existing holdings, group arrangements, voting rights and nomination rights. Seller is responsible for timely personal filings and the accuracy of his information. Applicable SEC filing deadlines control and are not extended by the contractual definition of Business Day.
Buyer shall use commercially reasonable efforts to obtain the stockholder approval required by Section 5.01(d), prepare and file the required proxy or information materials, respond to SEC comments and complete the applicable solicitation, meeting, voting or legally available written-consent process. Preliminary materials, delivery and waiting periods shall comply with the applicable proxy or information-statement rules. Seller and the Company shall provide information and cooperation reasonably requested for that process, and Seller shall abstain from a vote to the extent required by applicable Law or governing requirements. Closing may not precede completion of the required approval and any applicable waiting period.
Seller represents and covenants that information he and the Company furnish for inclusion in any proxy or information statement, Form 8-K, Form D, Nasdaq submission or other filing will not, at the time furnished and at the time of the stockholder meeting or consent, contain any untrue statement of a material fact or omit any material fact necessary to make it not misleading, including Rule 14a-9 under the Exchange Act. Seller shall promptly correct any such information that becomes inaccurate.
From the Execution Date until the transactions and all material non-public information concerning them have been publicly disclosed or cease to be material, Seller shall comply with Buyer’s insider-trading policy and applicable securities Laws and shall not trade in AIFA Common Stock or tip another Person while aware of material non-public information.
The Parties shall make, and cooperate in making, all SEC, Nasdaq, Section 16, beneficial-ownership, transfer-agent and other filings and approvals required to effect any surrender, cancellation, escrow release or retransfer under Sections 3.05 and 9.08, and Seller shall not take any action to delay or obstruct them.
Seller shall not use his position as a director or chairman of Buyer to direct, influence or participate in Buyer’s evaluation, negotiation, approval, enforcement or administration of this Agreement, except to provide information at the request of the Special Committee. Any decision by Buyer concerning a waiver, amendment, dispute, indemnification claim or enforcement against Seller shall be made by the Special Committee or another independent and disinterested body authorized by Buyer’s board. Nothing in this Agreement limits Seller’s fiduciary duties to Buyer or its stockholders.
20
Section 8.05 Financial Statement and Audit Cooperation.
Seller and the Company shall provide records, management representation letters, consents and other cooperation reasonably required for PCAOB audits and Buyer’s SEC filings, including after Closing for pre-Closing periods. Seller shall cause relevant personnel and accountants to cooperate, subject to customary access and privilege protections.
Section 8.06 Confidentiality and Public Announcements.
Each Party shall keep non-public information about the other Parties and the transactions confidential and use it only for the transactions, except information that is public without breach, already lawfully known, received lawfully without restriction or independently developed. Buyer may make disclosures it determines, after consulting counsel, are required or advisable under applicable securities Laws, SEC rules or Nasdaq Rules. Where lawful and practicable, the disclosing Party shall consult the other Parties in advance regarding disclosure that identifies them or describes the transaction.
Section 8.07 Further Assurances.
Before and after Closing, each Party shall execute documents and take actions reasonably requested to obtain approvals, transfer the Purchased Shares, preserve Seller Personal IP rights, the IP Cooperation Agreement and all other Personal IP Partner arrangements and carry out this Agreement.
Section 8.08 IP Revenue Collection and Compliant Operations.
| (a) | “IP Revenue” means all direct or indirect revenue, income, receipts and economic benefits, in cash or in kind, generated by or attributable to any Key Personal IP Partner from and after Closing, including Seller and Seller Personal IP, irrespective of channel, territory, contractual payee or collection intermediary. It includes content, licensing, royalties, advertising, sponsorships, endorsements, appearances, services, courses, training, subscriptions, livestreaming, commerce, commissions, platform revenue shares and derivative exploitation, whether under existing or future arrangements. It also includes receipts from other Company Intellectual Property and Personal IP Partner rights used in the Business. From the Execution Date until Closing, all receipts from Seller Personal IP and Key Personal IP Partner rights, together with other existing Business receipts, shall be preserved and collected for the Company; from Closing the full continuing undertaking in Section 6.20 applies until expressly varied by a written amendment under Section 11.06 or prospectively ended upon Reversal Completion under Section 9.08(f). |
21
| (b) | From and after Closing, all IP Revenue shall belong exclusively to Buyer or a Wholly Owned Subsidiary, and shall be contracted for, invoiced and collected into accounts in the name and under the control of the entity lawfully holding the corresponding commercialization and revenue rights. The Company shall initially retain those rights and collection arrangements. Buyer may thereafter cause them to be lawfully assigned or novated to itself or another Wholly Owned Subsidiary, with all necessary counterparty consents, licenses, payment directions and legal, tax, accounting and platform formalities completed. A direction by Buyer alone does not transfer rights or release any continuing obligation. Before any entity holding such rights ceases to be a Wholly Owned Subsidiary, Buyer shall cause those rights and collection arrangements to be lawfully transferred to Buyer or another Wholly Owned Subsidiary. The last sentence does not apply to the return of the Company and its rights under Section 9.08; the transition provisions of Section 9.08(f) govern that return. |
No IP Revenue, including revenue from Seller Personal IP, may be recorded as revenue of, diverted to or retained for the benefit of any Person outside Buyer and its Wholly Owned Subsidiaries, including Seller, any other Key Personal IP Partner, a non-wholly-owned Affiliate, nominee or joint venture. Seller shall comply personally and procure each other partner’s compliance, without using side agreements, substituted payees or new channels to avoid this obligation. Any prohibited recipient must segregate and disclose the receipt immediately and remit it in full, without setoff, within two (2) Business Days; Seller shall procure that remittance. Pending remittance, Seller shall hold, and shall procure that each such recipient holds, the receipt in trust for the entity entitled to it. Late remittances bear interest at ten percent (10%) per annum from the date of receipt and shall be grossed up for any Tax deducted, other than Tax properly withheld under paragraph (c). Buyer may set off any unremitted amount against any amount payable to Seller or his Affiliates by Buyer or its Subsidiaries, and may recover it from the Consideration Shares under Section 9.07. This deadline does not permit collection outside the group or prevent the initial diversion from being a material breach. Non-cash benefits shall be delivered or lawfully assigned to Buyer or the Wholly Owned Subsidiary entitled to them, or held solely for that entity pending lawful realization.
22
| (c) | Ordinary banking and platform payment processors may transmit funds solely as collection conduits, with the entity entitled to the revenue under paragraph (b) remaining the sole beneficial payee. Mandatory tax withholding and binding platform deductions must be documented, disclosed to and reviewed by Buyer, with full gross-to-net reconciliation; they do not permit a partner or related entity to retain revenue. Bona fide partner remuneration, royalties and operating costs may be paid as separately documented expenses approved by Buyer, rather than diverted revenue or undisclosed netting. Each recipient must account under applicable accounting standards, including principal-versus-agent rules; this contractual allocation does not require improper gross recognition. No consent under this paragraph can permit a beneficial recipient outside Buyer and its Wholly Owned Subsidiaries or release the full revenue obligation. |
| (d) | Seller and the Company shall, and Seller shall procure that the Key Personal IP Partners, comply with applicable Law and binding platform rules in carrying out all covered activities, including all exploitation of Seller Personal IP. Required IP, personality-rights, advertising, consumer-protection, e-commerce, tax, permit, privacy and data-transfer permissions must be obtained and maintained. Unauthorized content, misleading promotions, fabricated traffic and conflicting grants are prohibited. At Closing, the Company shall have lawful control of relevant contracts, content, administrative credentials and settlement accounts for Seller Personal IP and all other covered IP. After Closing, Seller shall not change, or procure any change to, any credential, recovery contact, payee, settlement account or administrative setting of those accounts without Buyer’s prior written consent. Seller irrevocably appoints Buyer as his attorney-in-fact, coupled with an interest, to give payment directions, change settlement accounts and take other actions with platforms and counterparties necessary to secure IP Revenue for the entity entitled to it. After Closing, any transfer of that control shall comply with paragraph (b). A non-transferable account must be specifically disclosed and addressed by a lawful arrangement accepted by Buyer that preserves the revenue entitlement. No provision requires breach of Law or platform rules. |
| (e) | The Company shall maintain complete contracts, invoices, platform statements, banking and IP compliance records covering Seller Personal IP and all other Key Personal IP Partners. Buyer shall maintain equivalent records for IP Revenue it receives and shall cause each Wholly Owned Subsidiary receiving IP Revenue to maintain equivalent records and provide access under this paragraph. Monthly revenue reconciliations shall be delivered to Buyer within fifteen (15) Business Days after month-end. Seller shall provide his relevant personal IP records and procure cooperation by the other Key Personal IP Partners and his controlled Affiliates. Buyer, its auditors and the Special Committee may inspect records and platform data on reasonable notice, or promptly on reasonable suspicion of diversion or material noncompliance, subject to applicable privacy and privilege protections. If an inspection reveals unremitted or diverted IP Revenue exceeding five percent (5%) of IP Revenue for the period examined, Seller shall bear the costs of the inspection. Records shall be retained for at least seven years, or longer if Law requires. |
| (f) | Seller and the Company shall notify Buyer within two (2) Business Days after becoming aware of diverted revenue, a material IP or regulatory claim, loss of a material right or permit, a material platform sanction or a breach of the revenue undertaking, in each case whether concerning Seller Personal IP or any other Key Personal IP Partner. They shall preserve evidence, stop unlawful activity and implement corrective action. No material settlement, waiver or admission may be made without Buyer’s consent, except action immediately required by Law. Seller’s responsibility to procure partner compliance under Section 6.20 is not limited to controlled Affiliates; the independent-act qualification in Section 6.20(c) applies. |
| (g) | Whether concerning Seller Personal IP or any other Key Personal IP Partner, any breach of Section 6.20 or this Section 8.08 for which Seller is responsible under Section 9.01, including any prohibited revenue receipt, retention, diversion or attribution, failure to remit, conflicting grant or operational noncompliance, entitles Buyer to exercise its rights under Section 9.08 without a minimum amount, materiality threshold or prior opportunity to cure. Buyer is entitled, at its election, to surrender and cancellation of all Consideration Shares concurrently with its return of all equity in the Company to Seller, and additionally to remittance and compensation for Losses, in each case on the terms of Section 9.08. Seller shall promptly remedy the breach and stop any continuing noncompliance; subsequent cure or remittance does not extinguish Buyer’s accrued election right unless Buyer expressly waives it through its independent body under Sections 8.04 and 9.04. The two-Business-Day remittance duty and rights to urgent relief continue. The revenue undertaking survives expiry of underlying arrangements unless expressly amended under Section 11.06 or prospectively ended under Section 9.08(f). |
23
Section 8.09 Related Party Review and Closing Compliance.
(a) Before Closing, Buyer shall document the Special Committee’s independence, disinterestedness, mandate and informed review of all material interests, the price, valuation, IP rights and final terms, including the reciprocal return mechanism in Section 9.08. Seller shall not participate in its deliberations or votes except to answer requested factual questions. The committee shall approve the transaction in good faith after obtaining advice it considers appropriate, and the board shall authorize issuance. These are agreed governance safeguards implementing Buyer’s related-party policy and the ongoing independent review required by Nasdaq Rule 5630; they do not alone establish compliance with every issuance rule. U.S. counsel shall assess the applicable Delaware General Corporation Law Section 144 process, including any controller or control-group issue. The fairness opinion required by Section 5.01(e) shall be obtained before the committee’s final approval.
(b) Buyer shall submit the Listing of Additional Shares notification under Nasdaq Rule 5250(e)(2) at least fifteen (15) calendar days before issuance, unless Nasdaq expressly permits a different timetable. The submission shall disclose Seller’s interests, actual and potential issuances, related transactions, beneficial ownership and all governance rights. Buyer shall satisfy the Nasdaq-related requirements in Section 5.01(d), resolve Nasdaq inquiries and complete any Rule 5110(a) initial listing process before consummation. Neither filing the notification nor passage of fifteen days is deemed clearance.
(c) Before issuance, U.S. securities counsel shall document an available Securities Act registration exemption, the necessary investor-status and offering-condition diligence, any disqualification checks, required legends and state-law steps. Buyer shall confirm sufficient authorized shares, valid board authorization and transfer-agent readiness. The relevant board or committee shall specifically approve Seller’s acquisition and the contemplated surrender and reciprocal retransfer mechanism under Section 9.08 in advance to the extent needed for the intended Rule 16b-3 exemption; a committee used for that purpose must consist solely of at least two Non-Employee Directors as defined in that rule. Nasdaq independence alone does not establish that separate status. No SEC merits approval of an exempt private issuance is assumed.
24
(d) Buyer shall timely disclose the signed material definitive agreement under applicable Form 8-K requirements and file the material agreement as required. Buyer and its advisers shall determine the applicability of Items 1.01, 2.01, 3.02, 5.01, 5.02 and 9.01 to signing, issuance, Closing and any governance changes, using the applicable SEC deadlines, generally four U.S. business days after the triggering event. Item 404 related-person disclosure must be included in the reports in which it is required. Buyer shall make required public announcements and give Nasdaq MarketWatch prior notice under Rule 5250(b)(1) and IM-5250-1. Nothing in this Agreement permits delaying a filing or public disclosure until Closing if it is due earlier.
(e) Before Closing, Buyer and its accountants shall complete the acquired-business significance analysis, identify required historical and pro forma financial information under Regulation S-X and confirm a timetable and resources to meet all filing deadlines. Seller and the Company shall supply the information required by Sections 4.02(f) and 8.05. A permitted post-Closing extension for acquired-business financial statements is available only if its legal conditions are satisfied; the Agreement creates no extension. Seller shall arrange required Form 4 reporting, generally within two U.S. business days, and any Schedule 13D or amendment, generally within five and two U.S. business days respectively when applicable. Buyer shall make any Form D filing within fifteen calendar days after the first sale if Regulation D is used, any required state notice, and any Nasdaq outstanding-share notification when due. Counsel shall determine the actual triggering date, which may precede Closing.
(f) Before Closing, Buyer shall compile a closing file containing the independent-review and board records, the stockholder approval evidence required by Section 4.03(c), Nasdaq correspondence and notification evidence, the counsel compliance analysis, exemption documentation, transfer-agent instructions and SEC reporting timetable. Pre-Closing requirements must be completed before issuance; later-due filings remain binding post-Closing obligations.
Section 8.10 Non-Competition, Non-Solicitation and Continued Service.
(a) From the Execution Date until the later of three (3) years after Closing and one (1) year after Seller ceases to serve as a director, officer or employee of Buyer or any of its Subsidiaries (the “Restricted Period”), Seller shall not, and shall cause his controlled Affiliates not to, directly or indirectly, (i) engage in, own, manage, operate or provide services to any business that competes with the Business within the geographic markets in which the Business is conducted at Closing, as specifically identified in Schedule A, while Buyer or a successor to the acquired goodwill carries on a like business there, other than through the Company or as authorized in writing by Buyer for Buyer or a Wholly Owned Subsidiary, (ii) solicit, induce or encourage any Key Personal IP Partner, employee or contractor of the Company to terminate or adversely modify its relationship with the Company, or (iii) commercialize, or authorize or assist any other Person to commercialize, any Seller Personal IP other than through the Company under the IP Cooperation Agreement or through Buyer or a Wholly Owned Subsidiary to which the relevant rights have been lawfully transferred under Section 8.08(b). This paragraph ceases to apply prospectively upon Reversal Completion.
25
(b) During the Restricted Period, Seller shall devote such time and attention to the Business as is reasonably necessary to preserve its relationships and revenue, and shall continue to make his personal identity, content and participation available to the Company on the terms of the IP Cooperation Agreement. The Parties acknowledge that the restrictions in this Section 8.10 are reasonable, are given in connection with the sale of all of Seller’s equity in and goodwill of the Company, and are necessary to protect the value acquired by Buyer. Expiry of the Restricted Period or cessation of Seller’s service does not release the independent exclusivity, non-diversion and revenue obligations under the IP Cooperation Agreement and Sections 6.20, 8.03 and 8.08, which continue in accordance with their terms, subject to Section 9.08(f) and non-waivable mandatory Law.
ARTICLE IX
Indemnification
Section 9.01 Indemnification by Seller.
From and after Closing, Seller shall indemnify Buyer, the Company, other Wholly Owned Subsidiaries entitled to IP Revenue under Section 8.08(b) and their representatives against Losses arising from: (a) breach of Seller’s or the Company’s representations; (b) breach of their covenants; (c) Company Taxes attributable to pre-Closing periods, including the pre-Closing portion of a straddle period; (d) Encumbrances on the Purchased Shares; (e) the Pre-Closing Restructuring; (f) an IP Protection Claim; and (g) pre-Closing fraud or willful misconduct by Seller or the Company. “IP Protection Claim” means any claim, however framed (including as a breach of representation, warranty, covenant or undertaking, or as an indemnity claim), arising out of or relating to (i) Sections 6.07 (as it relates to Key Personal IP Partner agreements), 6.08 through 6.12, 6.20, 8.03, 8.08 or 8.10, or the obligations of Seller under Section 9.08; (ii) the IP Cooperation Agreement covering all Seller Personal IP or any other Key Personal IP Partner undertaking; (iii) the Pre-Closing Restructuring; (iv) any third-party claim that Company Intellectual Property, Seller Personal IP or the conduct of the Business infringes, misappropriates or violates any Person’s Intellectual Property, publicity or personality rights; or (v) any receipt, retention or diversion of IP Revenue outside Buyer and its Wholly Owned Subsidiaries. Seller’s liability includes his express obligation to procure partner compliance under Section 6.20. For other Company post-Closing defaults, Seller is liable only to the extent caused or assisted by him, his controlled Affiliates or persons acting at his direction; the qualification in Section 6.20(c) applies.
Section 9.02 Indemnification by Buyer.
From and after Closing, Buyer shall indemnify Seller against Losses arising from breach of Buyer’s representations, warranties or covenants, or fraud or willful misconduct by Buyer. Except for fraud or willful misconduct, the De Minimis Amount and Deductible Basket apply to claims for breach of Buyer’s representations and warranties, and Buyer’s aggregate liability under this Section 9.02 may not exceed fifteen percent (15%) of the Purchase Price for those claims and the Purchase Price for all claims. Buyer has no liability for any decline in the trading price or value of the Consideration Shares, except to the extent caused by Buyer’s fraud or willful misconduct.
26
Section 9.03 Survival and Limitations.
The representations and warranties in this Agreement, other than Fundamental Representations and Tax representations, survive until eighteen (18) months after Closing.
“Fundamental Representations” means the representations and warranties concerning organization, authority, enforceability, capitalization, title, brokers, sanctions, Seller’s interested-director disclosures, ownership and control of Seller Personal IP and absence of conflicting grants, and the Closing rights and revenue entitlements, including but not limited to those in Section 6.01 (Organization and Qualification), Section 6.02 (Authority and Enforceability, including Seller’s interested-director disclosures), Section 6.03 (Capitalization and Title), Section 6.08 (Seller Personal IP and the IP Cooperation Agreement), Section 6.10 (Data Privacy and Cybersecurity), Section 6.16 (Anti-Corruption Sanctions and AML), Section 6.20(a) (Seller Personal IP and Key Personal IP Partner Revenue) and Section 6.21 (Broker). They survive for six (6) years after Closing. Tax representations survive until sixty (60) days after expiration of the applicable limitation period. Covenants survive according to their terms; in particular, the continuing obligations in Sections 6.20(b) and (c) and 8.08 are not subject to the eighteen-month period, but remain subject to Section 9.08(f).
Except for claims relating to Fundamental Representations, Tax representations, IP Protection Claims, covenants or Excluded Claims, to which neither the De Minimis Amount nor the Deductible Basket applies, no indemnification claim may be brought for an individual Loss of less than US$25,000 (the “De Minimis Amount”). Seller is liable for general representation claims only after aggregate qualifying Losses exceed one percent (1%) of the Purchase Price, and then only for Losses exceeding that amount (the “Deductible Basket”). For purposes of this Article IX, including determining whether a breach or inaccuracy has occurred and calculating Losses, each representation and warranty shall be read without regard to any materiality, “Material Adverse Effect” or similar qualifier, other than in the defined term “material Contract” and in any list required to be set out on a Disclosure Schedule. Seller’s aggregate liability for general representation claims may not exceed fifteen percent (15%) of the Purchase Price. General representation claims exclude Fundamental Representations, Tax representations and IP Protection Claims. Liability for Fundamental Representations and Tax representations may not exceed the Purchase Price. None of the limitations in this Section 9.03 applies to Losses arising from fraud, intentional misrepresentation or willful misconduct of Seller or, before Closing, the Company.
IP Protection Claims are not subject to the De Minimis Amount or Deductible Basket. Monetary compensation for Losses on those claims is capped in aggregate at the Purchase Price, except that the obligation to account for, return or remit IP Revenue belonging to Buyer or any Wholly Owned Subsidiary is not capped. Fraud, intentional misrepresentation and willful misconduct are not subject to any threshold or monetary cap. Surrender and cancellation of all Consideration Shares concurrently with return of the Company under Section 9.08, and any cash payable solely for an unavailable-share shortfall under Section 9.08(b), are separate from and additional to monetary compensation and are not charged against, reduced by or limited to that compensation cap. The source-of-recovery restriction in Section 9.07 does not apply to IP Protection Claims. Monetary recoveries for the same revenue or Loss shall be credited to prevent duplicate monetary compensation; the reciprocal share returns, cumulative monetary remedies and required accounting for the effect of reversal are governed by Section 9.08. No other recovery mechanism increases an otherwise applicable monetary cap.
27
Section 9.04 Claims Procedure.
An indemnified Party shall give reasonably prompt notice of a claim, but delay will relieve the indemnifying Party only to the extent materially prejudiced. For a third-party claim, the indemnifying Party may assume the defense with counsel reasonably acceptable to the indemnified Party, but may not settle without consent if the settlement includes non-monetary relief, an admission, or liability not fully paid by the indemnifying Party. The indemnified Party may participate with its own counsel at its expense.
While Seller serves as a director, officer or chairman of Buyer, any decision by Buyer to assert, settle, release, waive or compromise a claim against Seller under this Agreement shall be made exclusively by the Special Committee or another independent and disinterested body of Buyer’s board. Seller shall not receive privileged Buyer materials concerning such claim except as required for due process or applicable Law.
Section 9.05 Remedies After Closing.
Subject to the express exceptions in Sections 9.03, 9.07 and 9.08, indemnification is the exclusive monetary remedy after Closing. This does not limit the reciprocal full-share surrender and return of the Company, revenue remittance and additional compensation expressly required by Section 9.08, fraud or willful misconduct claims, equitable relief or rights under a preserved Ancillary Document. The prohibition on duplicate recovery of the same revenue or monetary Loss does not itself convert the cumulative remedies in Section 9.08 into alternatives or a proportionate share remedy; the reciprocal return and net-loss accounting provisions of Section 9.08, mandatory Law and a final enforceable determination remain applicable.
Section 9.06 Specific Performance.
Each Party acknowledges that a breach may cause irreparable harm for which damages are inadequate. Subject to applicable procedural Law and the competent court’s discretion, a Party may seek specific performance, injunctive relief, preservation of property, evidence or conduct, or other available relief in addition to the remedies expressly available under this Agreement. Nothing in this Agreement dispenses with any proof, security or other condition required by that court or applicable Law.
28
Section 9.07 Limited Recourse and Exceptions.
| (a) | Except for an Excluded Claim, the sole and exclusive source of recovery for all Losses and other amounts owed by Seller under or in connection with this Agreement shall be the Consideration Shares (together with any securities, dividends and distributions issued or paid in respect of them, including on any split, recapitalization or reclassification) and, solely as provided in Section 9.07(c), proceeds from a permitted disposition of Consideration Shares. Buyer may first recover from Consideration Shares held in escrow under Section 3.05, which the escrow agent and transfer agent are irrevocably authorized to release to Buyer for cancellation upon a final determination or written agreement through the independent body, without further action by Seller. Seller shall promptly surrender the required number of Consideration Shares to Buyer for cancellation and execute any instrument reasonably requested to effect the surrender. “Excluded Claim” means a claim arising from Seller’s fraud, intentional misrepresentation or willful misconduct, an IP Protection Claim, or a claim to recover IP Revenue under Section 8.08 or amounts repayable under Section 9.08(e), which are Buyer’s own property rather than indemnifiable Losses. The source-of-recovery limitations in this Section 9.07 do not apply to an Excluded Claim or to a claim brought directly under an Ancillary Document, but the monetary limitations in Section 9.03 apply according to their terms. |
| (b) | A Consideration Share surrendered under this Section 9.07 is credited at the lesser of the Reference Price and the twenty-trading-day volume-weighted average price ending on the trading day before surrender. This valuation and credit rule does not apply to the full-share surrender or unavailable-share shortfall under Section 9.08, which is governed exclusively by that Section. |
| (c) | If Seller has transferred, encumbered or otherwise made unavailable Consideration Shares, whether or not in a transaction permitted by this Agreement, and the Consideration Shares then held by Seller, a permitted transferee or the escrow agent are insufficient to satisfy an amount recoverable under this Article IX, Buyer may recover in cash an amount not exceeding the greater of the net after-Tax proceeds actually received by Seller from those shares and, for shares transferred or encumbered in breach of this Agreement, their value determined under Section 9.07(b). If Seller fails to surrender any required Consideration Shares within five (5) Business Days after the amount is finally determined, Buyer may recover the corresponding value in cash. While an indemnification claim is pending, Seller shall not transfer or encumber Consideration Shares with a value under Section 9.07(b) equal to the claimed amount. For claims other than Excluded Claims, aggregate recoveries under this Section 9.07 may not exceed the value of the Total Consideration Shares determined under Section 9.07(b), and this Section 9.07 does not increase any otherwise applicable cap under Section 9.03. |
| (d) | Shares surrendered under Section 9.07 or 9.08 are released from Section 3.05 restrictions solely to permit lawful surrender and cancellation. Any permitted transferee shall comply with its joinder. The Parties shall cooperate in consistent Tax reporting of the actual surrender and any reciprocal return under Section 9.08, to the extent permitted by Law; no retroactive Tax rescission is assumed. |
29
Section 9.08 Full Share Surrender and Return
of the Company.
(a) Upon any breach of Section 6.20 or 8.08, of the representations in the second and third paragraphs of Section 6.08, of the IP Cooperation Agreement, of Section 8.10(a)(iii) or of any Fundamental Representation (as defined in Section 9.03) made by Seller or the Company, in each case for which Seller is responsible under Section 9.01 (a “Triggering Breach”), Buyer, acting exclusively through the independent body under Sections 8.04 and 9.04, may elect in its sole discretion, by notice under paragraph (c), to require Seller to surrender to Buyer for cancellation all Consideration Shares issued under this Agreement, and upon that election Buyer shall concurrently transfer and return to Seller all of the Purchased Shares and all other issued and outstanding equity interests in the Company, so that Seller again owns one hundred percent (100%) of the Company, free of any equity interest retained by Buyer or its Affiliates. Seller has no right to require or initiate a reversal, and Buyer may instead retain the Company and pursue its other remedies. Following an election, these are reciprocal obligations to reverse the share exchange; neither Party shall pay an additional purchase price for the returned equity. Seller shall additionally remit outstanding IP Revenue and compensate recoverable Losses under paragraph (d). Buyer’s election right arises on the Triggering Breach, without a minimum amount, materiality threshold or opportunity to cure, regardless of its amount, duration, frequency or intent or whether a monetary Loss has been quantified. The share number is not proportionate to Losses. The reciprocal exchange and the additional monetary obligations are cumulative, subject to paragraphs (c) through (g) and mandatory Law.
(b) Seller’s surrender covers the Total Consideration Shares actually issued at Closing, initially 1,280,000 shares, adjusted for any split, combination, share dividend, reclassification or other recapitalization. It includes shares held by Seller, through nominees or controlled vehicles, in escrow or a restricted holding, or by a transferee bound by a joinder. Seller shall procure their lawful delivery free of Encumbrances and obtain necessary third-party instructions and consents. Shares previously surrendered to Buyer and actually cancelled under this Agreement count toward that full number and shall not be cancelled twice; repeated Triggering Breaches do not create a second full share number. This paragraph does not include unrelated shares independently held by Seller.
If required Consideration Shares cannot lawfully be delivered because of a prior disposal, adverse third-party right or other legal impediment, Seller shall first take all lawful steps to restore and deliver them. For shares that remain unavailable when the reciprocal exchange is due under paragraph (c), Seller shall pay, as part of that exchange, a cash substitute equal to the unavailable share number multiplied by the greater of the adjusted Reference Price and the twenty-trading-day volume-weighted average price ending on the trading day before the exchange is due. If no reliable quotation exists, the adjusted Reference Price applies. A successor security or proceeds replacing the shares shall be applied without also charging a cash substitute for the same shares. This is a shortfall mechanism, not an option to retain available shares, and does not authorize cancellation of shares held by an unbound third party. Buyer’s reciprocal obligation to return the Company applies equally where the shortfall is satisfied by this cash substitute.
30
(c) Buyer, acting exclusively through the independent body under Sections 8.04 and 9.04, shall give written notice specifying the Triggering Breach, supporting evidence, the full share number and any remittance or Losses then claimed, and confirming its readiness to perform the reciprocal return. A completed loss calculation is not a condition to demanding the exchange. Seller may object with reasons within ten (10) Business Days. If the Triggering Breach and exchange obligation are acknowledged or not disputed within that period, the reciprocal exchange shall be completed within five (5) Business Days thereafter, subject to paragraph (e). Disputed liability shall be resolved under Section 11.05, with completion within five (5) Business Days after written settlement or a final enforceable determination, unless that determination provides otherwise. Pending resolution, all Consideration Shares shall remain in escrow, Seller shall not vote them or receive distributions on them, and Seller’s obligations under Sections 6.20, 8.08 and 8.10 continue in full. A dispute only about additional Losses does not delay an otherwise established exchange obligation or undisputed revenue remittance. Neither Seller’s surrender nor Buyer’s return shall be irreversibly completed without the other Party’s concurrent performance; conditional delivery and coordinated release instructions shall implement this requirement. The date on which both equity transfers take legal effect is “Reversal Completion”.
On notice supported by reasonable evidence of a Triggering Breach, Buyer may require preservation of all identified outstanding Consideration Shares, including the relevant restricted or escrow position, subject to applicable Law, third-party rights and court review. Buyer shall correspondingly preserve all Company equity and shall not cause any extraordinary distribution, dilution, disposal, Encumbrance or transfer of material Business assets or IP rights that would frustrate the return; ordinary-course operations may continue. Seller shall not frustrate either return. A disputed allegation does not authorize unilateral cancellation, a Company register change or transfer of control. Either Party may seek preservation or urgent relief under Section 9.06. The independent body may supplement Buyer’s monetary claim as Losses become ascertainable.
(d) In addition to the reciprocal equity returns, Seller shall remit all outstanding IP Revenue attributable to the period before Reversal Completion and compensate Buyer and the persons indemnified under Section 9.01 for recoverable Losses caused by the Triggering Breach, including reasonable investigation, remediation and enforcement costs. The monetary limitations and exceptions in Section 9.03 continue to apply. Neither Party may recover the same revenue or Loss twice. Compensation shall reflect the actual net Loss after accounting for the reversal, restitution and amounts already recovered; Buyer may not recover the acquisition value as if it had both retained the acquisition and failed to receive back its consideration. The reciprocal return itself does not discharge a distinct, uncompensated Loss or accrued revenue obligation, and Seller may not elect monetary compensation instead of returning available shares. Nothing increases the monetary caps in Section 9.03.
31
(e) Buyer shall procure delivery to Seller of the Purchased Shares, adjusted for recapitalizations, together with any other Company equity needed to restore Seller’s one hundred percent (100%) ownership, and shall procure any group holder’s participation. Any intervening transfer, reorganization or issue does not excuse that obligation; Buyer shall take all necessary lawful steps to restore and deliver the required equity. The returned equity shall be free of Encumbrances created by Buyer or its group, other than matters caused by Seller or expressly accepted by him. Buyer and the Company shall deliver executed transfer instruments, an updated Company stock ledger, corporate records and control of the Company’s accounts and records. Seller shall deliver the required surrender instruments and procure bound transferees’ and custodians’ performance. Buyer shall coordinate lawful cancellation with its transfer agent. As a condition to Buyer’s return, Seller shall repay, or cause the Company to repay, all capital contributions, loans and other funding provided to the Company by Buyer or its Affiliates after Closing, and all dividends and distributions received on the Consideration Shares, and Buyer may set off those amounts against any amount it owes Seller. These repayments are a return of Buyer’s own capital, not indemnifiable Losses, and are not subject to the De Minimis Amount, Deductible Basket, caps or other limitations in Section 9.03 or the source-of-recovery limitations in Section 9.07. The Company retains its liabilities as a matter of Law; the return does not itself transfer those liabilities to Buyer or Seller personally or create a new valuation adjustment.
The Parties shall promptly obtain the independent corporate approvals, consents, securities-law treatment, filings and any judgment recognition required to implement both returns, including compliance with applicable capital and creditor-protection requirements and any intended Rule 16b-3 exemption. Conditional instruments shall be delivered within paragraph (c)’s period; if a mandatory approval or legal impediment prevents completion, the Parties shall diligently resolve it and complete within five (5) Business Days after it is resolved. Neither side of the exchange shall be completed unlawfully or treated as effective merely by notice. No Party may create or rely on a self-induced impediment to avoid its obligation, and rights to specific performance and legally recoverable Losses remain available. These requirements do not permit Buyer to cancel all consideration while electing to retain the Company.
(f) Until Reversal Completion, the existing IP ownership, revenue, compliance and accounting obligations continue. At Reversal Completion, the Company ceases to be part of Buyer’s wholly owned group, and the obligations under Sections 6.20 and 8.08 to allocate future IP Revenue exclusively to Buyer or its Wholly Owned Subsidiaries cease prospectively. Buyer shall procure that the acquired IP commercialization rights, partner agreements, related Business assets and collection arrangements originating in the Company and subsequently transferred within Buyer’s group are lawfully returned to the Company, together with necessary consents, records and payment directions. Unrelated Buyer assets and IP are excluded. These return and transition provisions shall be reflected in the relevant Ancillary Documents. Future revenue from the returned Business and IP shall accrue to the Company or the person lawfully entitled to it under those returned arrangements, rather than to Buyer merely by reason of this Agreement. No transfer or termination of an unbound third party’s rights is effected by this Agreement alone.
32
The Parties shall reconcile pre- and post-Reversal Completion revenue, receivables and receipts so that amounts are allocated to the period and person entitled to them and are not recovered twice. Buyer’s accrued claims for pre-reversal diversion and other breaches, and the related evidence, record-retention, access and enforcement duties, survive. Company receipts already properly collected and applied in ordinary-course operations are not demanded again merely because the Company is returned. Pending a necessary third-party consent for a returned right, the Parties shall implement a lawful transitional arrangement preserving the Company’s economic benefit without breach of Law or the underlying contract. None of this revives a prior agreement superseded by Section 11.06 or alters a non-party’s separate contractual rights.
(g) Later cure, repayment, expiry of the Section 3.05 lock-up or termination of an underlying partner agreement does not release Buyer’s accrued election right or any obligation arising from an election made under paragraph (c) unless expressly waived in writing through the independent body. The acquisition is reversed only upon Reversal Completion, without retroactively invalidating lawful intervening acts or extinguishing accrued claims. If a competent court holds the reciprocal return or any cumulative remedy unenforceable, legally recoverable revenue, Losses and other lawful relief survive under Section 11.08, with no unlawful forfeiture or duplicate recovery. The reciprocal return, settlement, dispute-resolution and accrued-rights provisions survive to the extent necessary to give them effect.
ARTICLE X
Termination
Section 10.01 Termination Rights.
Before Closing, this Agreement may be terminated: (a) by Buyer, in its sole discretion, at any time and for any reason or no reason, upon written notice to Seller and the Company; (b) by written agreement of Buyer and Seller; (c) by either Buyer or Seller if Closing has not occurred by December 31, 2027 (the “Outside Date”), unless that Party’s material breach primarily caused the failure; (d) by a non-breaching Party if another Party materially breaches and fails to cure within thirty (30) days after notice, or the breach is not curable; or (e) by either Buyer or Seller if a final, non-appealable order permanently prohibits Closing.
Section 10.02 Effect of Termination.
Termination does not affect accrued rights, liability for fraud or willful breach before termination, or Sections 8.06, 10.02 and Article XI, which survive. Buyer has no liability solely for exercising Section 10.01(a). An Ancillary Document survives only as expressly provided in that document and preserved by Section 11.06. Termination does not revive any prior communication or agreement superseded by this Agreement. A post-Closing reversal is governed by Section 9.08, not by the pre-Closing termination rights in Section 10.01.
33
ARTICLE XI
Miscellaneous
Section 11.01 Notices.
Notices must be in writing and delivered by personal delivery, nationally recognized courier or email with confirmation, to the addresses below (or a replacement address notified in accordance with this Section):
| (a) | if to Buyer: |
All In FutureTech Alliance Inc.,
745 5th Ave, Suite 500, New York, NY 10151
Attention: President,
| (b) | if to Seller: |
Li Shanglong,
[REDACTED]
Email: [REDACTED];
and
| (c) | if to the Company: |
Little Vault Inc.,
[REDACTED]
Attention: Director,
Email: [REDACTED].
Section 11.02 Assignment.
No Party may assign this Agreement without the other Parties’ prior written consent, except Buyer may assign its rights to a wholly owned Affiliate while remaining liable for its obligations. Any prohibited assignment is void.
34
Section 11.03 Expenses.
Each Party shall bear its own legal, accounting, valuation, diligence and other costs and its own Tax liabilities relating to this Agreement and the transactions, except as expressly provided otherwise.
Section 11.04 Governing Law.
This Agreement and any non-contractual obligations arising out of or relating to it are governed by the laws of the State of Delaware, without giving effect to conflicts-of-law rules that would apply another jurisdiction’s laws.
Section 11.05 Dispute Resolution.
Any dispute, controversy, difference or claim arising out of or relating to this Agreement, including its existence, validity, interpretation, performance, breach or termination and any non-contractual claim, shall be submitted to the exclusive jurisdiction of the People’s Court of Haidian District, Beijing, the People’s Republic of China. If mandatory rules on subject-matter, hierarchical, exclusive or centralized jurisdiction require another court to hear the dispute, the dispute shall be submitted to the competent People’s Court determined under those rules, with the Parties’ choice of a Beijing forum given effect to the fullest extent permitted by Law. Each Party submits to that jurisdiction, subject to those mandatory rules. Court proceedings, service of process, evidence and any translation or security requirements shall follow applicable procedural Law. A Party may seek interim or conservatory relief, or recognition and enforcement of a judgment, from any court competent to grant it without waiving this forum agreement. No arbitration is required under this Agreement.
Section 11.06 Entire Agreement and Amendment.
This Agreement, including Schedule A and the Disclosure Schedules, constitutes the entire agreement among the Parties concerning the acquisition, consideration, covered IP and related arrangements. From the Execution Date it supersedes and replaces all prior and contemporaneous oral, written and electronic communications, negotiations, assurances, proposals, term sheets, letters of intent, memoranda, confirmation letters, commitments, contracts and other documents among any of the Parties concerning that subject matter, whether binding or non-binding and whether signed or unsigned. This includes any earlier version of this purchase agreement and any transaction confirmation letter. No earlier pricing, issuance, governance or payment undertaking remains independently enforceable or revives if this Agreement terminates.
Ancillary Documents executed and delivered expressly pursuant to this Agreement supplement it only within their stated purpose; they do not revive a superseded arrangement, narrow the obligations in Sections 6.20 or 8.08 or amend this Agreement by implication. In a conflict this Agreement controls unless a later written amendment signed by all Parties expressly identifies the provision being amended. Schedule A and Disclosure Schedules accepted in accordance with Section 6.19 are incorporated without further amendment, subject to that Section’s limits. Third-party contracts with persons who are not Parties are not extinguished by this integration clause and must be lawfully assigned, amended or terminated where required for Closing.
35
Any amendment must be in writing and signed by all Parties, with Buyer acting through the independent body under Section 8.04. A waiver must identify the matter waived and be signed by the Party granting it; no waiver is continuing. Nothing in this Section excludes liability for fraud or an accrued claim for fraudulent conduct, or limits a right that applicable Law prohibits the Parties from excluding.
Section 11.07 No Third-Party Beneficiaries.
This Agreement benefits only the Parties and their permitted successors and assigns, except indemnified persons under Article IX and Wholly Owned Subsidiaries holding rights to IP Revenue under Section 8.08(b), which are entitled to enforce Sections 6.20, 8.08 and 9.08. No other Person is a third-party beneficiary. Accrued rights and the prospective cessation of rights upon return of the Company are subject to Section 9.08(f).
Section 11.08 Severability.
If a provision is held invalid or unenforceable, it will be modified to the minimum extent necessary to make it enforceable while preserving intent, and the remaining provisions will remain effective.
Section 11.09 Counterparts and Electronic Signatures.
This Agreement may be executed in counterparts, including by electronic signature and PDF transmission. Each counterpart is an original and all counterparts form one instrument.
Section 11.10 Relationship of the Parties.
Nothing in this Agreement creates a partnership, joint venture or agency relationship among the Parties, or any fiduciary relationship among them in their capacities as Parties. Nothing in this Section limits or modifies the fiduciary duties Seller owes to Buyer and its stockholders as a director, officer or chairman of Buyer. Each Party acts for its own account.
Section 11.11 Effectiveness.
This Agreement shall become effective upon execution by all Parties. If the Parties sign on different dates, the Execution Date shall be the date of the last signature.
[Signature Page Follows]
36
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Execution Date.
ALL IN FUTURETECH ALLIANCE INC.
| By: | /s/ Yangyang Li | |
| Name: | Yangyang Li | |
| Title: | President & Director |
SELLER
| By: | /s/ Li Shanglong | |
| Name: | Li Shanglong | |
| Capacity: | Executing this Agreement solely in his individual capacity as Seller |
LITTLE VAULT INC.
| By: | /s/ Li Shanglong | |
| Name: | Li Shanglong | |
| Title: | Director |
37
SCHEDULE A
Key Personal IP Partners and Seller Personal IP
To be delivered to and accepted by Buyer in accordance with Section 6.19. This Schedule shall identify Seller in his personal capacity, all Seller Personal IP and each other Key Personal IP Partner, the covered rights and revenue streams, relevant contracts and platform accounts, required consents, and the execution and effectiveness status of the IP Cooperation Agreement and each other partner agreement. Seller and all Seller Personal IP remain covered whether or not separately listed. This Schedule shall also specifically identify the geographic markets in which the Business is conducted at Closing for purposes of Section 8.10(a)(i).
38
SCHEDULE 6.03
Subsidiaries and Equity Ownership
To be delivered to and accepted by Buyer in accordance with Section 6.19. This Schedule shall identify each Subsidiary of the Company and its issued equity as required by Section 6.01. If the Company has no Subsidiaries, this Schedule shall state “None”.
39
SCHEDULE 6.04
Required Consents and Approvals
To be delivered to and accepted by Buyer in accordance with Section 6.19.
40
SCHEDULE 6.05
Financial Statements and Disclosed Liabilities
To be delivered to and accepted by Buyer in accordance with Section 6.19.
41
SCHEDULE 6.07
Material Contracts and Personal IP Agreements
To be delivered to and accepted by Buyer in accordance with Section 6.19, including the IP Cooperation Agreement covering all Seller Personal IP and each other Key Personal IP Partner agreement, together with all amendments and related undertakings.
42
SCHEDULE 6.08
Intellectual Property Digital Assets and Platform Accounts
To be delivered to and accepted by Buyer in accordance with Section 6.19, including the Company’s rights in Seller Personal IP and the IP of each other Key Personal IP Partner, relevant licenses, domains, platform accounts, administrative credentials and any transfer or consent restrictions.
43
SCHEDULE 6.10
Data Privacy and Cybersecurity Matters
To be delivered to and accepted by Buyer in accordance with Section 6.19.
44
SCHEDULE 6.13
Key Employees Contractors and Compensation Arrangements
To be delivered to and accepted by Buyer in accordance with Section 6.19.
45
SCHEDULE 6.17
Related Party Transactions
To be delivered to and accepted by Buyer in accordance with Section 6.19.
46